Current Clinical Research Trials at CDCRI in San Diego
California Dermatology and Clinical Research Center in San Diego offers Dermatology Clinical Research studies for those suffering from skin issues. We have a friendly and helpful staff along with cutting edge equipment to provide the latest and greatest treatments for a variety of dermatological ailments. Below you can find a list of all current studies running at CDCRI in San Diego. If you are interested in joining a dermatology clinical research study, contact us today!
CLINICAL RESEARCH FOR LIP AUGMENTATION -
This study is comparing a new, injectable filler material to an already FDA-approved lip product (Restylane Silk) for its treatment of thin lips and perioral lines.
Qualified participants must be 21 or older with lips that are a certain level of thinness, which will be determined by the dermatologist during the patient’s first visit. Those enrolled will need to commit to 5 office visits over a 6 month period.
This study will begin enrolling soon! Contact us today to get your name on the list of potential participants and find out more information. As with all of our clinical trials, no insurance is needed and there is no cost to patients. Those who enroll will be compensated for their time and travel. Think your lips aren’t thin enough? You may still qualify. This study is looking for participants with darker skin tones to take part in order to support this drug’s safety
CLINICAL RESEARCH FOR EXCESSIVE SWEATING -
Just in time for summer, this study is comparing two strengths of a topical gel for its treatment of underarm sweating (axillary hyperhidrosis).
Eligible participants will receive study medication for up to one year, which is applied once daily. There is no placebo in the study, meaning all who enroll will receive an active medication! This study involves 17 office visits over a one year period.
As always, participants do not need to have health insurance and will be provided with the study medication as well as compensation for time. Sign up today to learn more and get an appointment scheduled with our board certified dermatologist.
CLINICAL RESEARCH FOR ROSACEA -
Would you use phrases such as “red and inflamed” or “dotted with pus-filled bumps” to describe the skin on your face? This study may be for you. Our newest clinical trial is testing an investigational product for treatment of papulopustular rosacea.
To qualify, you must be at least 18 years old and have moderate-to-severe papulopustular rosacea. Those who enroll will need to commit to six office visits over a three month period. Two out of every three patients who enroll will receive the active medication.
Compensation will be provided for each visit! If you have any questions or would like to set up an appointment with our board certified dermatologist, contact us by clicking the button below.
*Have adult acne? Give us a call. It may be rosacea.*
CLINICAL RESEARCH FOR FACIAL VITILIGO -
We are excited to announce a new study for a condition that needs attention - vitiligo. This clinical trial is testing a topical JAK Inhibitor solution for its treatment of the condition, specifically located on the face.
Qualified participants must be between the ages of 18 and 68 and have an active lesion or lesions of the face, approximately the size of a half dollar or bigger when combined. Those enrolled will need to commit to 11 office visits over a 24 week period.
If you think you would be a good fit, or would like to find out more information, click the button below to get started. As with all of our studies, patients do not need insurance and compensation will be provided for each visit!
CLINICAL RESEARCH FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA)
ORAL OR INJECTION MEDICATION
Tired of sacrificing time, sleep and money because of eczema? We currently have a few options for studies in this area. Two are using a JAK Inhibitor oral medication and one is using an injection for treatment of the disease. The drugs are all in their final phase of testing and following the trial, study data will be sent to the FDA for review and approval.
Qualified participants must have eczema on more than 10% of their body - this can include both rashes and itching. After treatment, those enrolled may have an opportunity to enter into a long-term extension program, receiving the medication at no cost.
For more information, or to set up an appointment contact us today! As with all of our studies, patients do not need insurance and will receive monetary compensation for time and travel.
CLINICAL RESEARCH FOR MILD ATOPIC DERMATITIS (ECZEMA) -
A study for those with mild-to-moderate eczema is testing an already FDA approved, non-steroid topical ointment. The drug is being tested in a placebo- controlled study to support its safety on the use of children as young as 2 years old!
At the moment, we are able to enroll patients age 12 and older. To qualify, you must have at least 5% of your body affected by eczema - this can include both rashes and itching. Participants must commit to 6 office visits over a 4 week period.
If you or someone you care for has eczema, give us a call or send us a message. No insurance is required and all medications, examinations and lab tests are at no cost to you!
CLINICAL RESEARCH FOR ALOPECIA AREATA -
An excellent opportunity to help treat a very challenging condition - alopecia areata. This placebo-controlled study is comparing two strengths of an investigational topical solution. The drug targets the specific part of the immune system that may be overactive in the scalp of patients with alopecia areata.
To qualify, participants need to have had alopecia areata for at least 6 months with 15%- 95% of the scalp affected. The study is about 6 months long and requires 11 office visits.
If you think you’re a good fit or would like more information, contact us today! As with all of our clinical trials, no insurance is needed and there is no cost to patients.
Look out for our alopecia universalis study coming in 2019!
CLINICAL RESEARCH FOR PSORIASIS -
If you’re struggling with thick patches of psoriasis on your body, this clinical trial may be for you. We are starting a placebo-controlled study testing an investigational injection medication for psoriasis.
Participants must be older than 18 and have at least 10% body area affected by psoriasis. The study will last about a year and involve 20 office visits. Any past use of Cosentyx, Taltz, Stelara, Tremfya or Ilumya will disqualify you from participating in this study.
If this sounds like an good fit for you, give us a call or send us a message today! No insurance needed. No cost to patients. Compensation for time and travel.
CLINICAL RESEARCH FOR SCALP PSORIASIS -
For those of you who are most bothered by psoriasis on your scalp, we have a placebo-controlled study starting soon. An already FDA-approved product is being compared to a new, generic version of the medication.
To qualify, you must be at least 18 years old and have more than 10% of your scalp affected by psoriasis. There are only three office visits over a one month period and 6 out of every 7 patients who enroll will receive an active medication.
As usual, compensation will be provided for each visit! If you have any questions or would like to set up an appointment with our board certified dermatologist, contact us by clicking the button below.
Contact CDCRI for more information on Clinical Research Studies
Are you interested in getting cutting edge treatment for skin issues and rashes? California Dermatology and Clinical Research Institute in San Diego offers treatment for a variety of ailments. If you are interested in participating in a dermatology research trial, please fill out the form below, or contact us today!